IONNI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 847
EU - Europa 485
AS - Asia 108
AF - Africa 31
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.476
Nazione #
US - Stati Uniti d'America 828
SE - Svezia 188
IT - Italia 99
BG - Bulgaria 52
CN - Cina 51
AT - Austria 39
DE - Germania 37
GB - Regno Unito 27
CA - Canada 19
CI - Costa d'Avorio 17
FR - Francia 17
SG - Singapore 15
SN - Senegal 14
IN - India 12
VN - Vietnam 12
RU - Federazione Russa 10
TR - Turchia 10
UA - Ucraina 7
HK - Hong Kong 5
SA - Arabia Saudita 3
AU - Australia 2
FI - Finlandia 2
NL - Olanda 2
PL - Polonia 2
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
EU - Europa 1
HR - Croazia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.476
Città #
Fairfield 122
Woodbridge 108
Chandler 88
Houston 84
Seattle 58
Ashburn 52
Sofia 52
Ann Arbor 50
Wilmington 42
Vienna 38
Cambridge 35
New York 30
Serra 26
Beijing 23
London 20
Florence 19
Princeton 19
Ottawa 18
Abidjan 17
Lawrence 17
Bremen 16
Medford 16
Dakar 14
Marseille 11
Dearborn 9
Frankfurt am Main 9
Nanjing 7
Pisa 7
Des Moines 6
Rome 6
San Diego 5
Vicopisano 5
Dong Ket 4
Hong Kong 4
Izmir 4
Lancaster 4
Jeddah 3
Kocaeli 3
Milan 3
Nanchang 3
Shanghai 3
Ankara 2
Aosta 2
Baotou 2
Changsha 2
Jinan 2
Kunming 2
Munich 2
New Delhi 2
Norwalk 2
Queens 2
Seacroft 2
Tianjin 2
Warsaw 2
Boardman 1
Bratislava 1
Brussels 1
Centerville 1
Chicago 1
Dallas 1
Hebei 1
Hefei 1
Highland 1
Istanbul 1
Le Casine-Perignano-Spinelli 1
Melbourne 1
Monmouth Junction 1
Ogden 1
Parma 1
Pordenone 1
Pune 1
Redmond 1
Redwood City 1
San Jose 1
Santiago 1
Shaoxing 1
Shenyang 1
Singapore 1
Sydney 1
Toronto 1
Villasanta 1
Zagreb 1
Totale 1.114
Nome #
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 136
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 135
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 113
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 108
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 105
Occurrence of Graves’ Orbitopathy and of Graves’ hyperthyroidism after a trauma to the eye 100
null 93
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) 93
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 91
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 80
Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis 71
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 70
Peripheral T and B lymphocytes do not correlate with Graves’ orbitopathy 70
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 69
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 63
Retinal, choroidal and optic disc analysis in patients with Graves' disease with or without orbitopathy 53
Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study 51
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 28
Totale 1.529
Categoria #
all - tutte 4.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.584


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201950 0 0 0 0 0 0 0 0 0 0 29 21
2019/2020317 29 19 25 18 38 32 28 27 31 22 42 6
2020/2021166 10 6 6 22 12 3 24 13 11 20 22 17
2021/2022264 0 4 1 27 64 21 2 13 32 39 6 55
2022/2023390 46 71 42 32 28 40 3 33 66 0 28 1
2023/2024108 6 12 13 10 16 32 7 10 2 0 0 0
Totale 1.529